These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1171 related items for PubMed ID: 24356885

  • 1. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS.
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb 15; 306(4):G320-7. PubMed ID: 24356885
    [Abstract] [Full Text] [Related]

  • 2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov 15; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 3. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM.
    Hepatology; 2007 Jun 15; 45(6):1366-74. PubMed ID: 17476695
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
    Yin Y, Yu Z, Xia M, Luo X, Lu X, Ling W.
    Eur J Clin Invest; 2012 Nov 15; 42(11):1189-96. PubMed ID: 22958216
    [Abstract] [Full Text] [Related]

  • 5. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
    Zhang J, Tan Y, Yao F, Zhang Q.
    Mol Med Rep; 2012 Oct 15; 6(4):815-20. PubMed ID: 22858825
    [Abstract] [Full Text] [Related]

  • 6. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
    Lin Z, Wu ZF, Jiang CH, Zhang QW, Ouyang S, Che CT, Zhang J, Yin ZQ.
    Phytomedicine; 2016 Nov 15; 23(12):1475-1483. PubMed ID: 27765368
    [Abstract] [Full Text] [Related]

  • 7. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.
    Eur J Gastroenterol Hepatol; 2008 Sep 15; 20(9):843-54. PubMed ID: 18794597
    [Abstract] [Full Text] [Related]

  • 8. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
    Baumgardner JN, Shankar K, Hennings L, Badger TM, Ronis MJ.
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan 15; 294(1):G27-38. PubMed ID: 17947452
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of a Cirsium setidens extract on hepatic fat accumulation in mice fed a high-fat diet via the induction of fatty acid β-oxidation.
    Noh H, Lee H, Kim E, Mu L, Rhee YK, Cho CW, Chung J.
    Biosci Biotechnol Biochem; 2013 Jan 15; 77(7):1424-9. PubMed ID: 23832362
    [Abstract] [Full Text] [Related]

  • 10. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
    Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G.
    Transl Res; 2012 Jun 15; 159(6):477-86. PubMed ID: 22633099
    [Abstract] [Full Text] [Related]

  • 11. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction.
    Jun DW, Cho WK, Jun JH, Kwon HJ, Jang KS, Kim HJ, Jeon HJ, Lee KN, Lee HL, Lee OY, Yoon BC, Choi HS, Hahm JS, Lee MH.
    Liver Int; 2011 Oct 15; 31(9):1315-24. PubMed ID: 22093454
    [Abstract] [Full Text] [Related]

  • 12. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
    Kathirvel E, Morgan K, French SW, Morgan TR.
    Nutr Res; 2013 Nov 15; 33(11):932-41. PubMed ID: 24176233
    [Abstract] [Full Text] [Related]

  • 13. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ, Shi L, Song GY, Zhang HF, Hu ZJ, Wang C, Zhang DH.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):89-95. PubMed ID: 23791610
    [Abstract] [Full Text] [Related]

  • 14. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
    Yamamoto T, Nakade Y, Yamauchi T, Kobayashi Y, Ishii N, Ohashi T, Ito K, Sato K, Fukuzawa Y, Yoneda M.
    World J Gastroenterol; 2016 Feb 28; 22(8):2512-23. PubMed ID: 26937139
    [Abstract] [Full Text] [Related]

  • 15. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.
    Ganji SH, Kashyap ML, Kamanna VS.
    Metabolism; 2015 Sep 28; 64(9):982-90. PubMed ID: 26024755
    [Abstract] [Full Text] [Related]

  • 16. Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats.
    Perra A, Simbula G, Simbula M, Pibiri M, Kowalik MA, Sulas P, Cocco MT, Ledda-Columbano GM, Columbano A.
    FASEB J; 2008 Aug 28; 22(8):2981-9. PubMed ID: 18434432
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.
    J Gastroenterol Hepatol; 2012 Feb 28; 27(2):341-50. PubMed ID: 21929649
    [Abstract] [Full Text] [Related]

  • 18. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Okada Y, Yamaguchi K, Nakajima T, Nishikawa T, Jo M, Mitsumoto Y, Kimura H, Nishimura T, Tochiki N, Yasui K, Mitsuyoshi H, Minami M, Kagawa K, Okanoue T, Itoh Y.
    Liver Int; 2013 Feb 28; 33(2):301-11. PubMed ID: 23295058
    [Abstract] [Full Text] [Related]

  • 19. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.
    Matsunami T, Sato Y, Ariga S, Sato T, Shimomura T, Kashimura H, Hasegawa Y, Yukawa M.
    Metabolism; 2011 Jun 28; 60(6):805-14. PubMed ID: 20846698
    [Abstract] [Full Text] [Related]

  • 20. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A.
    Liver Int; 2011 Oct 28; 31(9):1285-97. PubMed ID: 21745271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.